Category: Uncategorized
Verona Collective to Double Its Existing Cannabis Dispensaries with New Locations in Sherrill and Chittenango The Oneida Indian Nation’s seed-to-sale cannabis enterprise will open a new dispensary in Sherrill on January 16 and another in Chittenango on January 23 with plans to open two additional locations by the end of the year.
Interlocutory Appeal Could Impact Cannabis Rescheduling Hearing New evidence prompted rescheduling advocates’ second effort to oust the DEA from the hearing; if relief is denied, they will seek the appeal.
Minnesota’s Top Cannabis Regulator Resigns; Adult-Use Sales Launch Date Still Unknown Charlene Briner, the Office of Cannabis Management’s interim director, is stepping down as adult-use regulations remain unfinalized.
DEA Approves Marion McNabb as Expert Witness for Cannabis Rescheduling Hearing The doctor in public health will testify as a proponent for reclassifying cannabis to a Schedule III drug under the Controlled Substances Act.
Klutch Cannabis to Rebrand Dispensaries, Launch Cookies Products in January 2025 The vertically integrated Ohio operator is focused on creating a unified experience while also offering globally recognized genetics.
6 Cannabis Industry Legal Cases, Policy Reforms and Trends to Watch in 2025 2024 was another busy and interesting year of legal and political developments for cannabis. Here are some key issues and must-watch cases for the year ahead.
Agrify Closes Sale of Cultivation Business The move further simplifies the company’s business model and balance sheet.
Delaware’s Top Cannabis Regulator Resigns Amid Adult-Use Rollout Rob Coupe, whose public service career spans 40 years, stepped down two weeks after awarding dispensary licenses but before the state’s sales launch.
The Cannabist Co. Expands New Jersey Footprint With Dispensary Opening in Mays Landing The company’s third dispensary in New Jersey began serving medical patients on Dec. 30, 2024, with adult-use sales to follow.
Attorney General, DEA Director, Judge Under Federal Court Summons Over DEA Marijuana Policy Despite the DEA’s policy, MMJ International is moving forward with the FDA on cannabis drug development for Huntington’s disease.